CCL18 and idiopathic pulmonary fibrosis: CCL18 is therefore an important M2 biomarker; its concentrations are elevated not only in serum of IPF patients but also in other ILDs with active fibrosis, and to a lesser extent in serum of patients with bronchial asthma and rheumatoid arthritis [33, 34].